PCH
KYMR icon

Polar Capital Holdings’s Kymera Therapeutics KYMR Stock Holding History

Polar Capital Holdings’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Sell
203,747
-11,453
-5% -$984K 0.06% 163
2026
Q1 		$17.9M Buy
215,200
+14,254
+7% +$1.13M 0.06% 153
2025
Q4 		$15.6M Sell
200,946
-196,095
-49% -$13.2M 0.06% 171
2025
Q3 		$22.5M Buy
397,041
+147,041
+59% +$6.63M 0.11% 140
2025
Q2 		$10.9M Buy
+250,000
New +$8.61M 0.06% 185

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Polar Capital Holdings's KYMR Position: Q2 2026 in Review

Polar Capital Holdings reduced its Kymera Therapeutics (KYMR) stake by 5.3% in Q2 2026, selling an estimated $984K and leaving 203,747 shares worth $23.4M. The position accounts for 0.06% of the portfolio, ranked #163.

Polar Capital Holdings first reported a position in KYMR in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Polar Capital Holdings held 203,747 shares of Kymera Therapeutics worth $23.4M as of Q2 2026.
  • Polar Capital Holdings sold 11,453 Kymera Therapeutics shares in Q2 2026, an estimated $984K.
  • Kymera Therapeutics made up 0.06% of Polar Capital Holdings's portfolio in Q2 2026, its #163 holding.
  • Polar Capital Holdings first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.